Back to User profile » Miss Meng Kuang
Paper published by Miss Meng Kuang:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Xu W, Kuang M, Gong Y, Cao C, Chen J, Tang C
OncoTargets and Therapy 2016, 9:4833-4842
Published Date: 4 August 2016